Similar companies
| Company | Stocktwits Subscribers | |
|---|---|---|
 |
AmgenAMGN |
15,009 0% |
 |
Gilead SciencesGILD |
77,592 0% |
 |
Catalyst PharmaceuticalsCPRX |
15,492 0% |
 |
Inovio PharmaceuticalsINO |
92,242 0% |
 |
Anavex Life SciencesAVXL |
23,921 0% |
Lexicon Pharmaceuticals Stocktwits Subscriber Count
Lexicon Pharmaceuticals (LXRX) has 13,558 subscribers on Stocktwits, roughly flat (-0.3%) over the past three months.
With 13,558 subscribers, Lexicon Pharmaceuticals has a smaller Stocktwits following than Amgen (15,009) and Gilead Sciences (77,592).
Unlike daily Stocktwits mentions, which spike around news and earnings, subscriber count reflects sustained, long-term interest from the retail investor community.
How LXRX’s Stocktwits Community Feeds the AI Score
Stocktwits subscriber count is a direct read on the size of the retail investor community tracking LXRX. It is not a stock price on its own, but sustained growth in subscribers can reflect building retail interest. AltIndex feeds Lexicon Pharmaceuticals’s Stocktwits community into the LXRX AI Score as one of 25+ alternative data signals, weighed against sentiment, Reddit activity, and fundamentals.
For daily discussion volume, see LXRX Stocktwits mentions. For other retail-community metrics, see Reddit subscribers and Reddit mentions.
Month over Month
| Sep 2026 | 13,559 | |
| Aug 2026 | 13,569 | |
| Jul 2026 | 13,599 | |
| Jun 2026 | 13,596 | |
| May 2026 | 13,622 | |
| Apr 2026 | 13,627 |
Lexicon Pharmaceuticals Stocktwits Subscribers: Frequently Asked Questions
Lexicon Pharmaceuticals (LXRX) has 13,558 subscribers (14K) on Stocktwits, based on AltIndex’s tracking of the stock’s Stocktwits page.
Lexicon Pharmaceuticals's Stocktwits subscriber base has been roughly flat (-0.3%) over the past three months. View the trend chart above for the full history.
Stocktwits subscriber count is a proxy for the size of the retail investor community tracking a stock. Unlike daily mentions, which spike around news, subscriber growth reflects sustained interest. No single data point predicts a stock on its own, which is why AltIndex combines LXRX’s Stocktwits community with sentiment, Reddit activity, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Lexicon Pharmaceuticals underperforms its industry peers when it comes to Stocktwits Subscribers, ranking in the 9th percentile.
StockTwits is a social media platform designed specifically for the investing community. It enables investors and traders to share market insights, strategies, and real-time news updates. Essentially, it's a specialized network for financial market discussions, often characterized by brief, tweet-like posts.
Sign up and get more insights on Lexicon Pharmaceuticals.
See Lexicon Pharmaceuticals’s complete stocktwits subscribers history
Sign up to unlock 1-year and all-time charts for LXRX, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
